person · Reporting owner
GLIMCHER LAURIE H M.D.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANALOG DEVICES INCADI · Entity 591 | Director | March 12, 2025 | March 14, 2025 |
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | February 01, 2017 | February 03, 2017 |
| WATERS CORP /DE/WAT · Entity 3080 | Director | January 02, 2020 | January 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANALOG DEVICES INC
Report date March 12, 2025 · Filed March 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Comm Stock - $.16-2/3 valueSEC Table I · non-derivative | Direct | 7,123 |
Reported balance
After 2025-03-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-12 · Grant · Acquired 1,160 · Balance 7,123 F1: Annual grant to non-employee director of Restricted Stock Units (RSUs) that vest 100% on the earlier of March 12, 2026 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F2: Includes 1,205 shares of common stock received from RSUs that vested on March 12, 2025 and were previously reported in Table II of Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant to non-employee director of Restricted Stock Units (RSUs) that vest 100% on the earlier of March 12, 2026 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company.
F2: Includes 1,205 shares of common stock received from RSUs that vested on March 12, 2025 and were previously reported in Table II of Form 4.
BRISTOL MYERS SQUIBB CO
Report date February 01, 2017 · Filed February 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 93,924.059 |
Reported balance
After 2017-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-02-01 · Grant · Acquired 3,448.975 · Balance 93,924.059 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
WATERS CORP /DE/
Report date January 02, 2020 · Filed January 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,067 |
Reported balance
After 2020-01-02 transaction · row 1
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 467 · Balance 4,067 F1: Grant of shares of common stock subject to restrictions that lapse January 2, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $235.06 · Expires 2030-01-02 | Direct | 1,601 |
Reported balance
After 2020-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-01-02 · Grant · Acquired 1,601 · Balance 1,601 F2: Options fully vest on January 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares of common stock subject to restrictions that lapse January 2, 2021.
F2: Options fully vest on January 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2025 Filed Mar 14, 2025 20:56 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantComm Stock - $.16-2/3 value | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000006281-25-000068 · wk-form4_1741985792.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,123 F1 · shares: Annual grant to non-employee director of Restricted Stock Units (RSUs) that vest 100% on the earlier of March 12, 2026 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F2 · balance_after: Includes 1,205 shares of common stock received from RSUs that vested on March 12, 2025 and were previously reported in Table II of Form 4. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:34 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantRestricted Stock Unit (RSU) · Derivative | 1,205 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-24-000080 · wk-form4_1710534881.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,205 Underlying: Comm Stock - $.16-2/3 value · 1,205 shares Expires not disclosed F1 · derivative.exercise_date: This RSU vests 100% on the earlier of March 13, 2025 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F1 · derivative.expiration_date: This RSU vests 100% on the earlier of March 13, 2025 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:39 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-24-000055 · wk-form4_1710275938.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Comm Stock - $.16-2/3 value · 1,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These RSUs vested 100% on March 8, 2024. On the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. F1 · derivative.expiration_date: These RSUs vested 100% on March 8, 2024. On the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:39 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionComm Stock - $.16-2/3 value | 1,228 | $0.00 | $0.00 |
DisclosureSEC source: 0000006281-24-000055 · wk-form4_1710275938.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:32 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-23-000069 · wf-form4_167848751510610.xml · derivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Comm Stock - $.16-2/3 value · 1,495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In accordance with the terms of the grant, this RSU vested 100% on March 8, 2023, the date of the Company's 2023 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. F2 · derivative.expiration_date: In accordance with the terms of the grant, this RSU vested 100% on March 8, 2023, the date of the Company's 2023 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:32 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantRestricted Stock Unit (RSU) · Derivative | 1,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-23-000069 · wf-form4_167848751510610.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Underlying: Comm Stock - $.16-2/3 value · 1,228 shares Expires not disclosed F1 · derivative.exercise_date: This RSU vests 100% on the earlier of March 8, 2024 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F1 · derivative.expiration_date: This RSU vests 100% on the earlier of March 8, 2024 or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 22:32 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionComm Stock - $.16-2/3 value | 1,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000006281-23-000069 · wf-form4_167848751510610.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:55 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,435 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-22-000057 · wf-form4_164703929042846.xml · derivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Comm Stock - $.16-2/3 value · 1,435 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In accordance with the terms of the grant, this RSU vested 100% on March 10, 2021, the date of the Company's 2021 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. F2 · derivative.expiration_date: In accordance with the terms of the grant, this RSU vested 100% on March 10, 2021, the date of the Company's 2021 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:55 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantRestricted Stock Unit (RSU) · Derivative | 1,495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-22-000057 · wf-form4_164703929042846.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495 Underlying: Comm Stock - $.16-2/3 value · 1,495 shares Expires not disclosed F1 · derivative.exercise_date: This RSU vests 100% on the earlier of one year from the grant date or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company F1 · derivative.expiration_date: This RSU vests 100% on the earlier of one year from the grant date or the date of the Company's next Annual Meeting of Shareholders. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:55 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionComm Stock - $.16-2/3 value | 1,435 | $0.00 | $0.00 |
DisclosureSEC source: 0000006281-22-000057 · wf-form4_164703929042846.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 21:27 UTC | ANALOG DEVICES INC ADI · Entity 591 | SaleComm Stock - $.16-2/3 value | 460 | $154.07 | $70,873.58 |
DisclosureSEC source: 0000006281-21-000118 · wf-form4_161601643648182.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:30 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,060 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-21-000056 · wf-form4_161550183219223.xml · derivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Comm Stock - $.16-2/3 value · 1,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In accordance with the terms of the grant, this RSU vested 100% on March 10, 2021, the date of the Company's 2021 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. F2 · derivative.expiration_date: In accordance with the terms of the grant, this RSU vested 100% on March 10, 2021, the date of the Company's 2021 Annual Meeting of Shareholders. Upon the vesting date, each vested RSU automatically converted into one (1) share of common stock of the Company. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:30 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantRestricted Stock Unit (RSU) · Derivative | 1,435 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-21-000056 · wf-form4_161550183219223.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435 Underlying: Comm Stock - $.16-2/3 value · 1,435 shares Expires not disclosed F1 · derivative.exercise_date: This RSU vests 100.00% on the earlier of the date of the Company's next Annual Meeting of Shareholder or March 10, 2022. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F1 · derivative.expiration_date: This RSU vests 100.00% on the earlier of the date of the Company's next Annual Meeting of Shareholder or March 10, 2022. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:30 UTC | ANALOG DEVICES INC ADI · Entity 591 | Exercise / conversionComm Stock - $.16-2/3 value | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0000006281-21-000056 · wf-form4_161550183219223.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:06 UTC | ANALOG DEVICES INC ADI · Entity 591 | GrantRestricted Stock Unit (RSU) · Derivative | 1,060 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000006281-20-000134 · wf-form4_160037319487533.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060 Underlying: Comm Stock - $.16-2/3 value · 1,060 shares Expires not disclosed F1 · derivative.exercise_date: This RSU vests 100.00% on the earlier of the date of the Company's next Annual Meeting of Shareholders, or March 11, 2021. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. F1 · derivative.expiration_date: This RSU vests 100.00% on the earlier of the date of the Company's next Annual Meeting of Shareholders, or March 11, 2021. Upon the vesting date, each vested RSU shall automatically convert into one (1) share of common stock of the Company. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:05 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 1,601 | $0.00 Strike: $235.06 | $0.00 |
DisclosureSEC source: 0001127602-20-000512 · form4.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601 Underlying: Common Stock · 1,601 shares Expires 2030-01-02 F2 · derivative.exercise_date: Options fully vest on January 2, 2021. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 20:05 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 467 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000512 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,067 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 2, 2021. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 13:30 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 2,200 | $214.64 | $472,208.00 |
DisclosureSEC source: 0001127602-19-031567 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 13:45 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 1,485 | $238.69 | $354,454.65 |
DisclosureSEC source: 0001127602-19-008594 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,800 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:38 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 1,760 | $0.00 Strike: $183.41 | $0.00 |
DisclosureSEC source: 0001127602-19-001133 · form4.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,760 Underlying: Common Stock · 1,760 shares Expires 2029-01-02 F2 · derivative.exercise_date: Options fully vest on January 2, 2020. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:38 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 599 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001133 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 2, 2020. Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 15:12 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GiftCommon Stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011064 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,686 Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 2,692 | $0.00 Strike: $195.69 | $0.00 |
DisclosureSEC source: 0001127602-18-000596 · form4.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,692 Underlying: Common Stock · 2,692 shares Expires 2028-01-02 F2 · derivative.exercise_date: Options fully vest on January 2, 2019. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:15 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 562 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000596 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,411 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 2, 2019. Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $75.94 | $0.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · derivative · entry 6 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $88.71 | $0.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · derivative · entry 5 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 800 | $175.80 | $140,640.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · nonDerivative · entry 4 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,849 Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 800 | $75.94 | $60,752.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · nonDerivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | SaleCommon Stock | 4,000 | $175.77 | $703,080.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · nonDerivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,849 Read SEC document |
| May 19, 2017 Filed May 22, 2017 13:39 UTC | WATERS CORP /DE/ WAT · Entity 3080 | Exercise / conversionCommon Stock | 4,000 | $88.71 | $354,840.00 |
DisclosureSEC source: 0001127602-17-018904 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,448.975 | $49.29 | $169,999.98 |
DisclosureSEC source: 0000014272-17-000039 · wf-form4_148616043409934.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,924.059 Underlying: Common Stock, $0.10 par value · 3,448.975 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:46 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 3,626 | $0.00 Strike: $136.43 | $0.00 |
DisclosureSEC source: 0001127602-17-001026 · form4.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 3,626 shares Expires 2027-01-03 F2 · derivative.exercise_date: Options fully vest on January 3, 2018. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 20:46 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001026 · form4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,849 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 3, 2018. Read SEC document |
| February 01, 2016 Filed Feb 3, 2016 21:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 2,795.133 | $60.82 | $169,999.99 |
DisclosureSEC source: 0000014272-16-000272 · wf-form4_145453671169375.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,190.467 Underlying: Common Stock, $0.10 par value · 2,795.133 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 04, 2016 Filed Jan 5, 2017 20:17 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 3,761 | $0.00 Strike: $130.35 | $0.00 |
DisclosureSEC source: 0001127602-17-001013 · form4a.xml · derivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,761 Underlying: Common Stock · 3,761 shares Expires 2026-01-04 F1 · shares: The purpose of this amended filing is to correctly report the number of stock and stock option awards. F3 · derivative.exercise_date: Options fully vest on January 4, 2017. Read SEC document |
| January 04, 2016 Filed Jan 5, 2017 20:17 UTC Amendment | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001013 · form4a.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,043 F1 · shares: The purpose of this amended filing is to correctly report the number of stock and stock option awards. F2 · shares: Grant of shares of common stock subject to restrictions that lapse January 4, 2017. Read SEC document |
| February 01, 2015 Filed Feb 3, 2015 23:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 2,654.72 | $60.27 | $159,999.97 |
DisclosureSEC source: 0000014272-15-000045 · wf-form4_142300550859941.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,437.57 Underlying: Common Stock, $0.10 par value · 2,654.72 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2014 Filed Feb 4, 2014 21:51 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,192 | $50.12 | $159,983.04 |
DisclosureSEC source: 0000014272-14-000029 · wf-form4_139155067116094.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,109.45 Underlying: Common Stock, $0.10 par value · 3,192 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2013 Filed Feb 5, 2013 21:11 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,364 | $36.66 | $159,984.24 |
DisclosureSEC source: 0001225208-13-002971 · doc4.xml · derivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,186.27 Underlying: Common Stock, $0.10 par value · 4,364 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 3,500 | $0.00 Strike: $25.51 | $0.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · derivative · entry 9 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,500 shares Expires 2013-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 6, 2003. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 2,500 | $0.00 Strike: $25.70 | $0.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · derivative · entry 8 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,500 shares Expires 2014-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 4, 2004. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 2,500 | $0.00 Strike: $26.25 | $0.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · derivative · entry 7 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,500 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 3, 2005. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 2,500 | $0.00 Strike: $24.96 | $0.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · derivative · entry 6 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 2,500 shares Expires 2016-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 2, 2006. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 11,000 | $36.40 | $400,400.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · nonDerivative · entry 5 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,500 | $24.96 | $62,400.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · nonDerivative · entry 4 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,500 | $25.70 | $64,250.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · nonDerivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,500 | $26.25 | $65,625.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · nonDerivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2013 Filed Jan 30, 2013 21:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,500 | $25.51 | $89,285.00 |
DisclosureSEC source: 0001225208-13-002480 · doc4.xml · nonDerivative · entry 1 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 20:45 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionOption (right to buy) · Derivative | 3,500 | $0.00 Strike: $28.38 | $0.00 |
DisclosureSEC source: 0001225208-12-008092 · doc4.xml · derivative · entry 3 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 3,500 shares Expires 2012-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was May 7, 2002. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 20:45 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 3,500 | $33.18 | $116,130.00 |
DisclosureSEC source: 0001225208-12-008092 · doc4.xml · nonDerivative · entry 2 GLIMCHER LAURIE H M.D. · CIK 0001255051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.